Y Intercept Hong Kong Ltd Acquires 45,953 Shares of Maximus, Inc. $MMS

Y Intercept Hong Kong Ltd grew its holdings in Maximus, Inc. (NYSE:MMS) by 198.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 69,073 shares of the health services provider’s stock after purchasing an additional 45,953 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Maximus were worth $4,428,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Farther Finance Advisors LLC boosted its holdings in Maximus by 69.0% during the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after purchasing an additional 116 shares during the last quarter. Advisory Services Network LLC acquired a new stake in Maximus in the 3rd quarter valued at $32,000. Canada Pension Plan Investment Board bought a new stake in Maximus during the 2nd quarter worth about $35,000. Northwestern Mutual Wealth Management Co. lifted its position in Maximus by 225.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock worth $38,000 after buying an additional 304 shares in the last quarter. Finally, Richardson Financial Services Inc. boosted its stake in shares of Maximus by 29.6% during the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after buying an additional 103 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Maximus Stock Performance

NYSE:MMS opened at $55.80 on Monday. The company has a current ratio of 2.21, a quick ratio of 2.21 and a debt-to-equity ratio of 0.87. The stock has a 50 day simple moving average of $60.38 and a 200 day simple moving average of $72.80. Maximus, Inc. has a 1-year low of $52.73 and a 1-year high of $100.00. The stock has a market cap of $2.93 billion, a P/E ratio of 8.35 and a beta of 0.60.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter last year, the business earned $2.01 EPS. The company’s quarterly revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Research analysts anticipate that Maximus, Inc. will post 8.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on MMS. Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Finally, Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.